Free Trial
NYSE:NGVT

Ingevity (NGVT) Stock Price, News & Analysis

Ingevity logo
$58.11 +0.16 (+0.27%)
As of 01:55 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Ingevity Stock (NYSE:NGVT)

Key Stats

Today's Range
$57.73
$58.59
50-Day Range
$40.43
$57.90
52-Week Range
$28.49
$58.59
Volume
72,611 shs
Average Volume
259,461 shs
Market Capitalization
$2.12 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$55.00
Consensus Rating
Moderate Buy

Company Overview

Ingevity Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

NGVT MarketRank™: 

Ingevity scored higher than 38% of companies evaluated by MarketBeat, and ranked 131st out of 189 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Ingevity has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Ingevity has only been the subject of 2 research reports in the past 90 days.

  • Read more about Ingevity's stock forecast and price target.
  • Earnings Growth

    Earnings for Ingevity are expected to grow by 17.98% in the coming year, from $4.45 to $5.25 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Ingevity is -9.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Ingevity is -9.76, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Ingevity has a P/B Ratio of 17.54. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Ingevity's valuation and earnings.
  • Percentage of Shares Shorted

    3.12% of the float of Ingevity has been sold short.
  • Short Interest Ratio / Days to Cover

    Ingevity has a short interest ratio ("days to cover") of 4.5.
  • Change versus previous month

    Short interest in Ingevity has recently decreased by 7.44%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Ingevity does not currently pay a dividend.

  • Dividend Growth

    Ingevity does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.12% of the float of Ingevity has been sold short.
  • Short Interest Ratio / Days to Cover

    Ingevity has a short interest ratio ("days to cover") of 4.5.
  • Change versus previous month

    Short interest in Ingevity has recently decreased by 7.44%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Ingevity has a news sentiment score of 1.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.70 average news sentiment score of Basic Materials companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Ingevity this week, compared to 4 articles on an average week.
  • Search Interest

    Only 1 people have searched for NGVT on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Ingevity insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.10% of the stock of Ingevity is held by insiders.

  • Percentage Held by Institutions

    91.59% of the stock of Ingevity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Ingevity's insider trading history.
Receive NGVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ingevity and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NGVT Stock News Headlines

Ingevity’s Earnings Call: Resilience Amid Challenges
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.tc pixel
Ingevity reports second quarter 2025 financial results
See More Headlines

NGVT Stock Analysis - Frequently Asked Questions

Ingevity's stock was trading at $40.75 at the beginning of the year. Since then, NGVT shares have increased by 42.5% and is now trading at $58.06.

Ingevity Corporation (NYSE:NGVT) released its quarterly earnings data on Monday, August, 4th. The company reported $1.39 EPS for the quarter, topping analysts' consensus estimates of $1.02 by $0.37. The company's revenue for the quarter was down 6.5% on a year-over-year basis.
Read the conference call transcript
.

Top institutional shareholders of Ingevity include American Century Companies Inc. (4.68%), State Street Corp (4.11%), Segall Bryant & Hamill LLC (3.52%) and Thrivent Financial for Lutherans (3.11%). Insiders that own company stock include Stuart Edward Jr Woodcock, Erik Spencer Ripple, Richard Allen White Jr and Phillip John Platt.
View institutional ownership trends
.

Shares of NGVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ingevity investors own include American Water Works (AWK), Waste Connections (WCN), DiamondRock Hospitality (DRH), Humana (HUM), AU Optronics (AUOTY), The RMR Group (RMR) and Voyager Therapeutics (VYGR).

Company Calendar

Last Earnings
8/04/2025
Today
8/29/2025
Next Earnings (Estimated)
11/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
CHEM - SPECIALTY
Sub-Industry
Chemicals
Current Symbol
NYSE:NGVT
Previous Symbol
NASDAQ:NGVT
CIK
1653477
Employees
1,600
Year Founded
2015

Price Target and Rating

High Price Target
$62.00
Low Price Target
$48.00
Potential Upside/Downside
-5.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($5.95)
Trailing P/E Ratio
N/A
Forward P/E Ratio
13.05
P/E Growth
N/A
Net Income
-$430.30 million
Net Margins
-16.35%
Pretax Margin
-18.49%
Return on Equity
84.92%
Return on Assets
7.95%

Debt

Debt-to-Equity Ratio
10.24
Current Ratio
1.36
Quick Ratio
0.80

Sales & Book Value

Annual Sales
$1.41 billion
Price / Sales
1.51
Cash Flow
$16.31 per share
Price / Cash Flow
3.56
Book Value
$3.31 per share
Price / Book
17.54

Miscellaneous

Outstanding Shares
36,470,000
Free Float
36,065,000
Market Cap
$2.12 billion
Optionable
Optionable
Beta
1.36

Social Links

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NYSE:NGVT) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners